ReviewPsychopharmacology2026
Co-use of cannabis and tobacco in the same occasion: Acute effects. A systematic review.
Review in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleCannabis and tobacco are widely used substances with addiction potential, which have opposing effects on cognition and subjective experience and are often co-used in a single occasion.
objectivesThe purpose of this systematic review was to synthesize evidence of the acute effects of same-occasion co-use of cannabis and tobacco.
methodsDatabases Embase, Medline, CINAHL, PsycINFO, and Web of Science were searched from inception to May 2025. Inclusion criteria were broad. Included studies were peer-reviewed papers, theses, grey literature and abstracts. Designs included randomized controlled trials, laboratory studies, epidemiological studies, qualitative studies, case reports, before-and-after studies, cohort, case-control, cross-sectional, longitudinal, secondary data analysis and naturalistic studies. Papers were screened and selected by two authors and studies were evaluated for quality with the SIGN methodology.
resultsIn total, 18 studies were included in the present synthesis, and some contained information on multiple outcomes. Five studies examined effects of same-occasion co-use of cannabis and tobacco on cognition; 12 studies evaluated same-occasion co-use on subjective experience; and seven studies evaluated effects on physiological measures. With respect to cognition, three studies found that cannabis and tobacco each attenuated the effects of the other, but the findings were not always consistent. For subjective experience, eight studies reported that the effects of same-occasion co-use of cannabis and tobacco did not differ from the effects of either drug on its own. Two studies of subjective experience found that tobacco dulled the effects of cannabis and two found that tobacco increased the stimulant properties of cannabis.
conclusionsIn sum, the evidence for additive effects of cannabis and tobacco is mixed, with some studies reporting that cannabis and tobacco attenuate the effects of the other on cognition. There are inconclusive findings with respect to the combined effects of cannabis and tobacco on subjective effects and physiological outcomes. However, studies are limited and more large-scale studies that investigate the full range of diverse effects of cannabis and tobacco are needed.
Indexed as
Identifiers
42831941What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.